William Blair Reiterates Outperform Rating on 9 Meter Biopharma (NMTR), Shares Have Assymetric Risk/Reward
Tweet Send to a Friend
William Blair analyst Tim Lugo reiterated an Outperform rating on 9 Meter Biopharma (NASDAQ: NMTR).The analyst comments: "We believe 9 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
